Seattle Genetics, Inc. (SGEN) - NASDAQ
From other sites
Company Description
Seattle Genetics, Inc. is a biotechnology company focused on the development and commercialization of monoclonal antibody-based therapies for cancer. Its product ADCETRIS or brentuximab vedotin has been approved by both U.S. Food and Drug Association and Health Canada in U.S. and Canada... More
Sector: Healthcare
Industry: Biotechnology
Country: United States